<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00642122</url>
  </required_header>
  <id_info>
    <org_study_id>SD-004-0764</org_study_id>
    <secondary_id>D5257L00012</secondary_id>
    <nct_id>NCT00642122</nct_id>
  </id_info>
  <brief_title>Adults With Moderate to Severe Asthma</brief_title>
  <official_title>A Randomized, Blinded, Multicenter, Parallel Study Comparing the Efficacy and Safety of Pulmicort Respules at 0.5mg QD, 1.0mg QD, 1.0mg Bid, 2.0mg Bid and Pulmicort Turbuhaler at 4.00mcg Bid on Adolescents (12 Yrs of Age and Older) With Adults With Moderate to Severe Asthma.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to compare the safety and effectiveness of 5 different ways of taking Pulmicort when
      given to asthma patients aged 12 years and above.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forced Expiratory Volume in 1 second in patients allocated treatment with Pulmicort REPSULES at 0.5mg and 2.0mg.</measure>
    <time_frame>Day -14, 1, and every 28 days thereafter</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of symptom free days</measure>
    <time_frame>Day -14, 1, and every 28 days thereafter</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of symptom free nights</measure>
    <time_frame>Day -14, 1, and every 28 days thereafter</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of symptom free 24-hours</measure>
    <time_frame>Day -14, 1, and every 28 days thereafter</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pulmicort RESPULES</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pulmicort TURBUHALER</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Budesonide</intervention_name>
    <description>0.5mg once daily</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Pulmicort RESPULES</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Budesonide</intervention_name>
    <description>1mg once daily</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Pulmicort RESPULES</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Budesonide</intervention_name>
    <description>1mg twice daily</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Pulmicort RESPULES</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Budesonide</intervention_name>
    <description>2mg once daily</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Pulmicort RESPULES</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Budesonide</intervention_name>
    <description>4.00mcg twice daily</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Pulmicort TURBUHALER</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female aged 12 or over who have asthma

          -  Ability to properly use an electronic diary

          -  Able and willing to nebulize for up to 20 minutes every morning and evening

        Exclusion Criteria:

          -  Hospitalised at least one once or required emergency treatment due to asthma in the
             previous 6 months

          -  Planned hospitalisation during the study

          -  pregnant women or women planning to become pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bertil Andersson</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca</affiliation>
  </overall_official>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2008</study_first_submitted>
  <study_first_submitted_qc>March 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2008</study_first_posted>
  <last_update_submitted>January 21, 2011</last_update_submitted>
  <last_update_submitted_qc>January 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2011</last_update_posted>
  <responsible_party>
    <name_title>Lars-GÃ¶ran Carlsson</name_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Pulmicort</keyword>
  <keyword>budesonide</keyword>
  <keyword>respules</keyword>
  <keyword>turbuhaler</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Budesonide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

